INTRA-CELLULAR THERAPIES INC (ITCI) Earnings History & Surprises
NASDAQ:ITCI • US46116X1019
131.87 USD
-0.05 (-0.04%)
At close: Apr 1, 2025
131.92 USD
+0.05 (+0.04%)
After Hours: 4/1/2025, 8:00:02 PM
Past quarterly earnings results for INTRA-CELLULAR THERAPIES INC (ITCI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 5, 2025
PeriodQ1 / 2025
EPS Estimate-$0.11
Revenue Estimate210.57M
Last Reported
Release DateFeb 21, 2025
PeriodQ4 / 2024
EPS Reported-$0.16
EPS Surprise -40.63%
Revenue Surprise 1.00%
Beat Rate
75%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2024 | -0.16 | -0.11 | -40.63% | 46.67% | 199.223M | 197.26M | 1.00% | 50.81% |
| Q3 2024 | -0.25 | -0.20 | -24.97% | - | 175.375M | 175.8M | -0.24% | 39.00% |
| Q2 2024 | -0.16 | -0.19 | 17.50% | 64.44% | 161.388M | 161.04M | 0.22% | 45.67% |
| Q1 2024 | -0.16 | -0.32 | 50.59% | 65.22% | 144.866M | 144.21M | 0.45% | 52.00% |
| Q4 2023 | -0.30 | -0.45 | 33.56% | 33.33% | 132.099M | 138.38M | -4.54% | 50.28% |
| Q3 2023 | -0.25 | -0.58 | 56.70% | 56.14% | 126.173M | 121.62M | 3.74% | 75.48% |
| Q2 2023 | -0.45 | -0.60 | 25.25% | 51.09% | 110.792M | 108.78M | 1.85% | 99.27% |
| Q1 2023 | -0.46 | -0.62 | 25.60% | 41.03% | 95.306M | 93.824M | 1.58% | 172.30% |
| Q4 2022 | -0.45 | -0.60 | 25.52% | 57.14% | 87.9M | 88.711M | -0.91% | 242.02% |
| Q3 2022 | -0.57 | -0.83 | 31.36% | 40.00% | 71.9M | 67.324M | 6.80% | 223.87% |
| Q2 2022 | -0.92 | -0.78 | -18.61% | -8.24% | 55.6M | 50M | 11.20% | 178.00% |
| Q1 2022 | -0.78 | -0.94 | 16.92% | -20.00% | 35M | 34.325M | 1.97% | 120.13% |
| Q4 2021 | -1.05 | -1.01 | -3.56% | -38.16% | 25.7M | 25.458M | 0.95% | 105.60% |
| Q3 2021 | -0.95 | -0.94 | -1.24% | -20.25% | 22.2M | 22.559M | -1.59% | 200.00% |
| Q2 2021 | -0.85 | -0.81 | -5.34% | 11.46% | 20M | 19.416M | 3.01% | 952.63% |
| Q1 2021 | -0.65 | -0.82 | 20.47% | 10.96% | 15.9M | 16.834M | -5.55% | 1,345.45% |
| Q4 2020 | -0.76 | -0.86 | 11.88% | - | 12.5M | 12.076M | 3.51% | - |
| Q3 2020 | -0.79 | -1.02 | 22.24% | - | 7.4M | 5.981M | 23.73% | - |
| Q2 2020 | -0.96 | -0.93 | -3.57% | - | 1.9M | 2.971M | -36.05% | - |
| Q1 2020 | -0.73 | -0.95 | 22.77% | - | 1.1M | 1.469M | -25.12% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
0.62%
Max EPS beat (4)
50.59%
Min EPS beat (4)
-40.63%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
0.36%
Max Revenue beat (4)
1.00%
Min Revenue beat (4)
-0.24%
Analysis
In the last 4 quarters, ITCI has beaten EPS estimates in 2 out of 4 releases
ITCI has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, ITCI has beaten the EPS estimates by 0.6% on average.
In the last 4 quarters, ITCI has beaten the revenue estimates by 0.4% on average.
INTRA-CELLULAR THERAPIES INC / ITCI Earnings FAQ
Can you provide the last earnings date for INTRA-CELLULAR THERAPIES INC?
INTRA-CELLULAR THERAPIES INC (ITCI) last reported earnings on 2/21/2025.
Did INTRA-CELLULAR THERAPIES INC (ITCI) beat earnings estimates last quarter?
INTRA-CELLULAR THERAPIES INC (ITCI) missed EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often INTRA-CELLULAR THERAPIES INC beats earnings estimates?
In the last 4 quarters, INTRA-CELLULAR THERAPIES INC (ITCI) has beaten EPS estimates in 2 out of 4 releases.